FSTX insider filings

F-star Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-09. Screen FSTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for FSTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — F-star Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-03-094Kayitalire Louis — CHIEF MEDICAL OFFICERCode (U): 29,236 @ $7.12 · Disposition to issuer (D): 25,019 @ $7.12 · Disposition to issuer (D): 27,289 (derivative) · Disposition to issuer (D): 12,880 (derivative) · Disposition to issuer (D): 53,634 (derivative) · Disposition to issuer (D): 35,719 (derivative)EDGAR
2023-03-094Forster Eliot — PRESIDENT AND CEO, DirectorCode (U): 347,578 @ $7.12 · Disposition to issuer (D): 73,959 @ $7.12 · Disposition to issuer (D): 127,924 (derivative) · Disposition to issuer (D): 165,028 (derivative) · Disposition to issuer (D): 126,909 (derivative)EDGAR
2023-03-094Klein Pamela M. — DirectorDisposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Other (J): 15,000 (derivative) · Other (J): 7,500 (derivative)EDGAR
2023-03-094Brady Todd C — DirectorCode (U): 15,004 @ $7.12 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Other (J): 11,000 (derivative) · Other (J): 10,964 (derivative) · Other (J): 5,500 (derivative) · +3 moreEDGAR
2023-03-094Brewis Neil — CHIEF SCIENTIFIC OFFICERCode (U): 105,088 @ $7.12 · Disposition to issuer (D): 9,375 @ $7.12 · Disposition to issuer (D): 22,561 (derivative) · Disposition to issuer (D): 74,263 (derivative) · Disposition to issuer (D): 132,469 (derivative)EDGAR
2023-03-094Race Geoffrey — DirectorCode (U): 3,937 @ $7.12 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-03-094Benz Edward JR — DirectorDisposition to issuer (D): 4,385 @ $7.12 · Disposition to issuer (D): 3,937 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-03-094Bermingham Nessan — DirectorCode (U): 97,547 @ $7.12 · Disposition to issuer (D): 6,328 @ $7.12 · Disposition to issuer (D): 34,111 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-03-094Arkowitz David — DirectorCode (U): 8,386 @ $7.12 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Other (J): 10,000 (derivative) · Other (J): 5,500 (derivative) · Other (J): 4,386 (derivative) · +4 moreEDGAR
2023-03-094DEPTULA-HICKS DARLENE M — See RemarksCode (U): 30,898 @ $7.12 · Disposition to issuer (D): 25,539 @ $7.12 · Disposition to issuer (D): 28,426 (derivative) · Disposition to issuer (D): 25,894 (derivative) · Disposition to issuer (D): 59,823 (derivative) · Disposition to issuer (D): 24,902 (derivative)EDGAR
2023-01-094Race Geoffrey — DirectorOption exercise (M): 3,937 @ $0.11 · Option exercise (M): 3,937 (derivative) @ $0EDGAR
2022-08-024Forster Eliot — President and CEO, DirectorOption exercise (M): 260,977 @ $0.11 · Option exercise (M): 32,602 (derivative) @ $0 · Option exercise (M): 228,375 (derivative) @ $0EDGAR
2022-08-024Brewis Neil — Chief Scientific OfficerOption exercise (M): 76,619 @ $0.11 · Option exercise (M): 6,307 (derivative) @ $0 · Option exercise (M): 70,312 (derivative) @ $0EDGAR
2022-06-224Brady Todd C — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Race Geoffrey — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Benz Edward JR — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Klein Pamela M. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Bermingham Nessan — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Arkowitz David — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-04-044Forster Eliot — President and CEO, DirectorGrant/award (A): 126,909 (derivative) @ $0EDGAR
2022-04-044Kayitalire Louis — Chief Medical OfficerGrant/award (A): 35,719 (derivative) @ $0EDGAR
2022-04-044Brewis Neil — Chief Scientific OfficerGrant/award (A): 132,469 (derivative) @ $0EDGAR
2022-04-044DEPTULA-HICKS DARLENE M — Treasurer and CFOGrant/award (A): 24,902 (derivative) @ $0EDGAR
2022-01-114Kayitalire Louis — Chief Medical OfficerGrant/award (A): 53,634 (derivative) @ $0EDGAR
2022-01-114Brewis Neil — Chief Scientific OfficerGrant/award (A): 74,263 (derivative) @ $0EDGAR
2022-01-114Forster Eliot — President and CEO, DirectorGrant/award (A): 165,028 (derivative) @ $0EDGAR
2022-01-114DEPTULA-HICKS DARLENE M — Treasurer and CFOGrant/award (A): 59,823 (derivative) @ $0EDGAR
2021-11-044Kayitalire Louis — Chief Medical OfficerSale (S): 39 @ $6.81 · Sale (S): 25 @ $6.85EDGAR
2021-10-064Kayitalire Louis — Chief Medical OfficerSale (S): 64 @ $7.23EDGAR
2021-08-244/AKayitalire Louis — Chief Medical OfficerGrant/award (A): 26,437 @ $0EDGAR
2021-08-244/ABermingham Nessan — DirectorGrant/award (A): 16,875 @ $0EDGAR
2021-08-244/ADEPTULA-HICKS DARLENE M — Treasurer and CFOGrant/award (A): 26,437 @ $0EDGAR
2021-07-074Kayitalire Louis — Chief Medical OfficerSale (S): 1,054 @ $8.43EDGAR
2021-06-074Krol Patrick Johan Hendrik — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Klein Pamela M. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Brady Todd C — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Race Geoffrey — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Benz Edward JR — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Bermingham Nessan — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-074Arkowitz David — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-03-114Kayitalire Louis — Chief Medical OfficerGrant/award (A): 12,880 (derivative) @ $0EDGAR
2021-03-114Forster Eliot — President and CEO, DirectorGrant/award (A): 127,924 (derivative) @ $0EDGAR
2021-03-114Brewis Neil — Chief Scientific OfficerGrant/award (A): 22,561 (derivative) @ $0EDGAR
2021-03-114DEPTULA-HICKS DARLENE M — Treasurer and CFOGrant/award (A): 25,894 (derivative) @ $0EDGAR
2021-02-024Brewis Neil — Chief Scientific OfficerGrant/award (A): 18,000 @ $0EDGAR
2021-02-024Forster Eliot — President and CEO, DirectorGrant/award (A): 142,000 @ $0EDGAR
2021-02-024Kayitalire Louis — Chief Medical OfficerGrant/award (A): 29,000 @ $0EDGAR
2021-02-024Benz Edward JR — DirectorGrant/award (A): 4,385 @ $0EDGAR
2021-02-024Bermingham Nessan — DirectorGrant/award (A): 87,000 @ $0EDGAR
2021-02-024DEPTULA-HICKS DARLENE M — Treasurer and CFOGrant/award (A): 30,000 @ $0EDGAR

Recent 8-K events — F-star Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-03-098-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-068-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-238-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
EDGAR
2023-02-098-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-018-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-308-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-298-K8.01 — Other EventsEDGAR
2022-12-218-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-198-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FSTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs